rHEALTH receives NIH support to advance fingertip-based diagnostics for Hemophilia A, enabling rapid, accessible testing of FVIII and emicizumab levels worldwide — from clinics to remote, underserved regions.

A major milestone in space medicine — NASA has deployed DMI’s rHEALTH ONE blood analyzer aboard the International Space Station, bringing rapid, autonomous diagnostics one step closer to supporting long-duration spaceflight and delivering transformative healthcare benefits for Earth.